NIH Announces Phase III Clinical Trial of Creatine for Parkinson's Disease

NIH Announces Phase III Clinical Trial of Creatine for Parkinson's Disease
posted by net1978 452 days 1 hour 47 minutes ago

The NIH National Institute of Neurological Disorders and Stroke (NINDS) today is launching a large-scale clinical trial to learn if the nutritional supplement creatine can slow the progression of Parkinson's disease (PD).

• 3 votes
• vote for it